Baird Financial Group Inc. Has $3.71 Million Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Baird Financial Group Inc. lifted its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 2.9% during the 4th quarter, Holdings Channel reports. The fund owned 28,073 shares of the financial services provider’s stock after acquiring an additional 800 shares during the quarter. Baird Financial Group Inc.’s holdings in iShares Biotechnology ETF were worth $3,712,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the business. Franklin Resources Inc. raised its stake in shares of iShares Biotechnology ETF by 3.3% in the third quarter. Franklin Resources Inc. now owns 18,285 shares of the financial services provider’s stock worth $2,664,000 after acquiring an additional 580 shares during the last quarter. International Assets Investment Management LLC acquired a new position in iShares Biotechnology ETF during the 4th quarter worth $433,000. Graypoint LLC boosted its position in iShares Biotechnology ETF by 10.3% in the 4th quarter. Graypoint LLC now owns 1,779 shares of the financial services provider’s stock valued at $235,000 after buying an additional 166 shares during the last quarter. Aprio Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at $18,476,000. Finally, Capital Investment Advisors LLC raised its position in shares of iShares Biotechnology ETF by 1.0% during the fourth quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock worth $1,381,000 after acquiring an additional 99 shares during the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Down 2.2 %

iShares Biotechnology ETF stock opened at $116.59 on Friday. The stock has a market cap of $5.10 billion, a price-to-earnings ratio of 25.09 and a beta of 0.84. iShares Biotechnology ETF has a 12-month low of $107.43 and a 12-month high of $150.57. The business’s 50-day simple moving average is $125.40 and its 200 day simple moving average is $133.48.

iShares Biotechnology ETF Increases Dividend

The firm also recently announced a dividend, which was paid on Friday, March 21st. Investors of record on Tuesday, March 18th were issued a dividend of $0.1212 per share. This is a boost from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date was Tuesday, March 18th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.